Cyrus Harmon
Founder en OLEMA PHARMACEUTICALS, INC. .
Fortuna: 11 M $ al 31/03/2024
Perfil
Cyrus L.
Harmon is the founder.
He founded Neomorphics, Inc. in 1996, where he served as the Chief Executive Officer from 1996 to 2000.
He also founded Olema Pharmaceuticals, Inc. in 2006 and currently holds the title of Director.
In addition to his founding positions, Dr. Harmon previously worked at Affymetrix, Inc. as the General Manager from 2000 to 2002.
Dr. Harmon obtained his undergraduate and doctorate degrees from the University of California, Berkeley.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
28/03/2024 | 948 311 ( 1.70% ) | 11 M $ | 31/03/2024 |
Cargos activos de Cyrus Harmon
Empresas | Cargo | Inicio |
---|---|---|
OLEMA PHARMACEUTICALS, INC. | Founder | 07/08/2006 |
Antiguos cargos conocidos de Cyrus Harmon.
Empresas | Cargo | Fin |
---|---|---|
AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2002 |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Chief Executive Officer | 01/01/2000 |
Formación de Cyrus Harmon.
University of California, Berkeley | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OLEMA PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Neomorphics, Inc. develops, analyzes, and manages genetic information to improve disease. The company is based in Berkeley, CA. The company was founded by Cyrus L. Harmon, Martin G. Reese. Neomorphics was acquired by Affymetrix, Inc., part of Thermo Fisher Scientific, Inc. from April 01, 2016 on October 31, 2000 for $85.92 million. | Health Technology |
- Bolsa de valores
- Insiders
- Cyrus Harmon